Showing results (341-350 of 528) with videos related to
Sort By:
Pageof 53
Neurobiology of Aging|April 22, 2017
Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson's diseaseElijah Mak, Li Su, Guy B Williams, et al.Plos One|November 19, 2013
Rare variants in PLXNA4 and Parkinson's diseaseEva C Schulte, Immanuel Stahl, Darina Czamara, et al.Movement Disorders : Official Journal of the Movement Disorder Society|July 23, 2017
A user's guide for α-synuclein biomarker studies in biological fluids: Perianalytical considerationsBrit Mollenhauer, Richard Batrla, Omar El-Agnaf, et al.International Journal of Methods in Psychiatric Research|April 19, 2017
Psychometric properties of the apathy evaluation scale in patients with Parkinson's diseaseUlrike Lueken, Ricarda Evens, Monika Balzer-Geldsetzer, et al.Scientific Reports|November 29, 2025
Intraarterial microbubble delivery enhances focused ultrasound induced blood brain barrier opening in the murine substantia nigraHsun Li, Yung-Han Lee, Xiao Zen, et al.Experimental Neurology|July 16, 2008
Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegenerationBrit Mollenhauer, Valerie Cullen, Ilana Kahn, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 26, 2012
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelinesIrene Litvan, Jennifer G Goldman, Alexander I Tröster, et al.JAMA Neurology|November 22, 2021
Association of Plasma p-tau181 and p-tau231 Concentrations With Cognitive Decline in Patients With Probable Dementia With Lewy BodiesMaria C Gonzalez, Nicholas J Ashton, Bárbara Fernandes Gomes, et al.Neurology|April 24, 2025
Investigating Plasma Metabolomics and Gut Microbiota Changes Associated With Parkinson Disease: A Focus on Caffeine MetabolismChieh-Chang Chen, Jian-Ying Chiu, Ai Huey Tan, et al.Parkinsonism & Related Disorders|August 21, 2021
A new CERAD total score with equally weighted z-scores and additional executive and non-amnestic "CERAD-Plus" tests enhances cognitive diagnosis in patients with Parkinson's disease: Evidence from the LANDSCAPE studyRobert Lillig, Anja Ophey, Jörg B Schulz, et al.Pageof 53